In acute promyelocytic leukemia (APL), retinoid receptor function is disrupted, demonstrated by the inhibition of RARA caused by a chromosomal translocation that creates the PML/RARA fusion protein, which blocks the differentiation of myeloid cells and drives cancer cell proliferation [71]. This evidence concerns the gene RARA and cancer.